alexa Hypercalcemia | Brazil| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Relevant Topics

Hypercalcemia

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Hypercalcemia

    Hypercalcemia: Hypercalcemia is a condition in which the calcium level in your blood is above typical. A lot of calcium in your blood can debilitate your bones, make kidney stones, and meddle with the way your heart and cerebrum works.

  • Hypercalcemia

    Disease Symptoms
    Kidneys. Abundance calcium in your blood implies your kidneys need to work harder to sift it through. This can bring about inordinate thirst and incessant pee. Digestive framework. Hypercalcemia can bring about stomach upset, sickness, spewing and clogging. Bones and muscles. As a rule, the abundance calcium in your blood was filtered from your bones, which debilitates them. This can bring about bone torment. A few individuals who have hypercalcemia likewise experience muscle shortcoming. Cerebrum. Hypercalcemia can meddle with the way your mind works, bringing about disarray, dormancy and weariness

  • Hypercalcemia

    Disease Treatment
    Drugs:Now and again, your specialist may prescribe: Calcimimetics. This sort of medication mirrors calcium circling in the blood, so it can control overactive parathyroid organs. Bisphosphonates. Intravenous osteoporosis medications can reconstruct bone debilitated by hypercalcemia. Dangers connected with this treatment incorporate osteonecrosis of the jaw and certain sorts of thigh breaks. Prednisone.

  • Hypercalcemia

    Statistics
    Survival did not differ in patients treated with different antihypercalcemic regimens but was longer (median, 135 days; P less than 0.001) in a subgroup of 26 patients for whom specific anticancer therapy was available. Polyuria and polydipsia improved after therapy in 83% of cases, central nervous system symptoms in 71%, constipation in 70%, nausea and vomiting in 56%, anorexia in 50%, and malaise and fatigue in 47% (all significant, P less than 0.001, pre-treatment compared with post-treatment).

 

High Impact List of Articles

Conference Proceedings